Pharmacology of antidepressant drugs and mood stabilisers Flashcards
Give the 8 classes of antidepressant?
and 2 examples of each
MAOI-monoamine oxidase inhibitors
(Phenelzine, Isocarboxazid)
RIMA-reversible monoamine oxidase inhibitor
(Moclobemide)
TCA- tricyclic antidepressant
(Amitriptyline, Clomipramine)
SSRI- selective serotonin reuptake inhibitor
(Fluoxetine, Paroxetine, Citalopram)
SNRI-Serotonin–norepinephrine reuptake inhibitor
(Venlafaxine, Duloxetine)
NARI- noradrenaline reuptake inhibitor
(Reboxetine)
NassA- Noradrenergic and specific serotonergic antidepressant
(Mirtazapine)
Other
(Trazodone, Nefazodone)
SSRIs
- give 3 examples
- used in what?
- mechanism of action?
- why is the effect delayed?
- adverse effects?
-Fluoxetine, Paroxetine, Citalopram
-depression panic disorder social anxiety PTSD OCD Chronic pain eating disorders stroke recovery prem ejaculation
-inhibit the re-uptake of 5-HT and so increase synaptic 5-HT
this stimulates the 5-HT receptors to inhibit firing
the effect takes 2-3 weeks to improve mood
chronic occupancy of the 5-HT receptor causes it to desensitise and there is a return of normal firing
-5-HT1a receptors are auto receptors throughout the CNS, they are inhibitory and so more receptors means greater inhibition
-sexual dysfunction
GI- nausea, dyspepsia, constipation etc
short term anxiety
in young people inc risk of self harm in a few weeks
Tricyclic antidepressants
- give 2 examples
- used in what?
- mechanism of action?
- adverse effects?
- Amitriptyline, Clomipramine
- depression & neuropathic pain
- serotonin-norepinephrine reuptake inhibitors (SNRIs) by blocking the serotonin transporter (SERT) and the norepinephrine transporter (NET), so get an elevation of the synaptic concentrations
-drowsiness dry mouth blurred vision constipation urinary retention effect on cardiac function and postural hypotension
Monoamine oxidase inhibitors
- give 2 examples
- mechanism of action?
- adverse effects?
- management of ^?
- restrictions?
-phenelzine, isocarboxazid
-inhibit monoamine oxidase A&B,
(MAO A metabolises NA, 5-HT and tyramine, MAO B metabolises DA, tyramine and phenylethylamine)
so get increased storage and availability for release of 5-HT and NA
-Tyramine is normally inactivated in the gut by MAO do hypertensive crisis can occur with tyramine containing food and some drugs e.g. cheese, yogurt, yeast extracts
drugs- sympathomimetics
symptoms: flushing, headache, inc BP
- alpha blockade e.g. phentolamine
- Dietary & drug interactions
what effects do antidepressants have on dopamine?
some give extrapyramidal SEs
likely that there is antagonism of DA receptors
GABA
- what is it?
- function?
- Give the 2 types of GABA receptor and their agonists?
- main inhibitory NT in mammalian brains
- opens ion channels and allows either CL into cell or K out of cell to give negative change in transmembrane potential and hyperpolarization
- GABAa- ligand gated ion channel
ethanol, benzos, propofol, anaesthetics
GABAb- Gprotien couples receptors
Baclofen, propfol
Mood stabilisers
- what are they?
- Give the 3 types of mood stabiliser and examples (3,2,2)
-mostly anti-convulsant drugs
tend to be better at reducing manic episodes than depressive ones
-Anti-convulsant drugs
(carbamazepine, valproate, Lamotrigine)
Atypical
olanzapine, risperidone
Others
Lithium carbonate , nimodipine
anti-convulsants
-MOA?
-increase inhibitory NT in the brain but all have different mechanisms
Lamotrigine
-MOA?
-blocks Na channels
reduces excitability and cell firing
lamotrigine may also inhibit 5-HT uptake aswell
Lithium
- MOA?
- SE?
- monitoring?
-unknown exactly why inhibition of 5-HT autoreceptors increase in anti apoptotic factor Bcl-2 inhibits GSK-3 Depletion of inositol up regulation of glutamate re-uptake
-risk of toxicity high
problems with poor adherence
-NEEDS BLOOD MONITORING
Antipsychotic drugs
- MOA for first generation and second generation (3) ?
- adverse effects?
-affinity for the D2 receptor, produces DA blockade in the mesolimbic circuits
2nd gen:
inc D2 receptor-binding affinity
inc 5-HT2c, 5-HT2a receptor binding affinity increases efficacy
inc 5-HT1a receptor binding affinity reduces efficacy
-due to DA blockade in the nigrostriatal and tubero-infundibular pathways:
weight gain